Literature DB >> 6246669

Protection of laying hens against infectious bronchitis with inactivated emulsion vaccines.

P G Box, A V Beresford, B Roberts.   

Abstract

Commercially-reared laying chickens were challenged at 31 weeks of age with a virulent infectious bronchitis (IB) virus. They showed a sharp drop in egg production, despite having been vaccinated at four and eight weeks old with live attenuated IB vaccines to a recommended schedule. In contrast, similar birds that had been further immunised at point-of-lay with inactivated oil emulsion IB vaccine, or with a combined IB/Newcastle disease (ND) emulsion vaccine, showed no detectable fall in egg production after the same challenge. Unvaccinated susceptible specific pathogen-free birds challenged at the same time stopped laying almost completely. In the birds revaccinated with emulsion vaccine, measurement of haemagglutination inhibition antibody levels to IB showed their geometric mean titres to be raised from less than 5 log2 at the time of vaccination to over 10 log2 four weeks later. Their antibody levels did not rise further followining the IB challenge whereas in the birds that had not been revaccinated antibody rises to nearly 10 log2 were detected after the same challenge. For pullets vaccinated earlier with live IB vaccine, revaccination with inactivated IB or IB/ND oil emulsion vaccine at point-of-lay provides a safe and effective way of protecting their egg production against IB infection.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6246669     DOI: 10.1136/vr.106.12.264

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  4 in total

Review 1.  Infectious bronchitis virus variants: a review of the history, current situation and control measures.

Authors:  J J Sjaak de Wit; Jane K A Cook; Harold M J F van der Heijden
Journal:  Avian Pathol       Date:  2011-06       Impact factor: 3.378

2.  Recombinant infectious bronchitis coronavirus H120 with the spike protein S1 gene of the nephropathogenic IBYZ strain remains attenuated but induces protective immunity.

Authors:  Yi Jiang; Xu Cheng; Xiumei Zhao; Yan Yu; Mingyan Gao; Sheng Zhou
Journal:  Vaccine       Date:  2020-02-11       Impact factor: 3.641

3.  Development of attenuated vaccines from Taiwanese infectious bronchitis virus strains.

Authors:  Yuan-Pin Huang; Ching-Ho Wang
Journal:  Vaccine       Date:  2005-09-07       Impact factor: 3.641

Review 4.  Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus.

Authors:  Dave Cavanagh
Journal:  Avian Pathol       Date:  2003-12       Impact factor: 3.378

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.